BioAmber Inc. (NYSE:BIOA) insider have most recently took part in a trading activity. On Nov 30, 2017 Wall Kenneth W., Director bought 40,000 shares having total worth of $17,200 at the price of $0.43 per share, following the transaction a total of 170,443 shares owned by Wall Kenneth W..
Furthermore, over the past 12 months , the stock was traded 2 times by insiders. an employee of the company was the buyer in 2 instances.
Shares of BioAmber Inc. (NYSE:BIOA) traded down 4.94% on Dec 1, 2017, hitting $0.42. 938,709 shares of the company’s stock traded hands. BioAmber Inc. has a 52 week low of $0.33 and a 52 week high of $6.36. The company’s market cap is $106 million.
BioAmber Inc. (NYSE:BIOA) last announced its earnings results on Nov 7, 2017. The company reported -0.21 earnings per share (EPS) for the quarter. The company had revenue of $3 million for the quarter, compared to the consensus estimate of $7 million. During the same quarter in the previous year, the company posted -0.26 earnings per share. The company’s revenue for the quarter was down 10% on a year-over-year basis.
|earnings per share||-0.21||-0.20||-0.31||-0.27||-0.26||-0.25||-0.29||-0.36||-0.36||-0.39|
BioAmber Inc was incorporated in the state of Delaware on October 15, 2008 as DNP Green Technology, Inc. It is a chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a variety of everyday products including plastics, resins, food additives and personal care products.
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018